Stockholders' Equity (Notes) |
9 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity, Attributable to Parent [Abstract] | |
| Stockholders' Equity Note Disclosure [Text Block] | Stockholders' Equity and Stock-Based Compensation Stockholders' Equity The Company has an effective shelf registration statement, filed with the Securities and Exchange Commission in September 2024, registering $750 million of equity securities, of which $300 million is reserved for sales under the at-the-market equity offering program that the Company entered into in November 2024. During the three and nine months ended June 30, 2026, the Company did not issue any shares under its at-the-market equity offering program. At June 30, 2026, the full $750 million remained available for issuance under the Company's shelf registration statement, with $300 million reserved for sales under the at-the-market equity offering program. Stock-Based Compensation The Company’s Stock Incentive Plan provides for the granting of equity awards, such as performance stock units (PSUs) and restricted stock units (RSUs), to executive officers, other key employees and non-management directors. PSUs are earned by achieving key performance criteria and RSUs are earned through continued employment with the Company over a requisite time period. Each stock unit represents the contingent right to receive one share of the Company’s common stock if the performance criteria and/or vesting conditions are satisfied. The stock units have no dividend or voting rights until vested. In October 2025, the Company granted 114,565 PSUs to its executive officers. The number of units that ultimately vest depends on the achievement of four performance criteria which are (i) relative total stockholder return, (ii) return on inventory, (iii) market share goals, and (iv) book value per share, and can range from 0% to 200% of the number of units granted. The four performance criteria are weighted equally. These awards vest at the end of a year performance period ending September 30, 2028. The grant date fair value of these equity awards was $27.94 per unit. Compensation expense related to this grant was $0.3 million and $0.8 million in the three and nine months ended June 30, 2026, respectively, based on an estimate of the Company’s achievement of the four performance criteria, the elapsed portion of the performance period and the grant date fair value of the award. In the nine months ended June 30, 2026, a total of 321,285 RSUs were granted. The weighted average grant date fair value of these equity awards was $27.07 per unit, and they vest annually in equal installments over periods of to years. Compensation expense related to this grant was $0.4 million and $2.2 million in the three and nine months ended June 30, 2026, respectively. Stock-based compensation expense in the nine months ended June 30, 2026 included $1.1 million of expense recognized for employees that were retirement eligible on the date of the grant. Total stock-based compensation expense related to the Company's equity awards for the three and nine months ended June 30, 2026 was $1.9 million and $6.9 million, respectively, compared to $1.5 million and $5.8 million in the prior year periods.
|